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Soft tissue sarcomas at a glance: clinical,
histological, and MR imaging features
of malignant extremity soft tissue tumors
Abstract Soft tissue sarcomas com-
prise approximately 1% of malignant
tumors. There are more than 50
subtypes, but pleomorphic sarcoma,
liposarcoma, leiomyosarcoma, syno-
vial sarcoma, and malignant periph-
eral nerve sheath tumor account for
75%. Differentiation between these
subtypes is difficult because they often
present with a painless enlarging
mass, and share many histological and
MR imaging features. Nonetheless,
subdifferentiation is important be-
cause the different subtypes have
different prognoses and therapeutic
strategies. In this manuscript we dis-
cuss the clinical, histological, and MR
imaging features of soft tissue sarco-
mas according to the WHO classifi-
cation. An overview is provided and
differentiating features are discussed
that can help to narrow down the
differential diagnosis.
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Introduction
Soft tissue sarcomas (STS) account for approximately 1%
of malignant tumors. There are more than 50 subtypes, but
pleomorphic sarcoma (formerly known as malignant
fibrous histiocytoma, MFH), liposarcoma, leiomyosarco-
ma, synovial sarcoma, and malignant peripheral nerve
sheath tumor account for 75%. Approximately 75% arise in
the extremities, but the trunk wall, retroperitoneum (RP),
and head and neck are also fairly common locations [1].
Soft tissue sarcomas usually do not arise from dedifferen-
tiation of benign soft tissue tumors but develop de novo.
The etiology of STS is unknown but some factors are
associated with a higher risk, including genetic and
environmental factors (e.g., chemical carcinogens), irradi-
ation, viral infections (HHV-8), and immune deficiency.
Sporadic cases also occur in areas of scarring and surgical
implants [2]. STS usually present as painless soft tissue
masses, often large at the time of diagnosis, and they
metastasize hematogenously, mainly to the lung. Initial
assessment of the lesion should be done with imaging
before biopsy as biopsy tracts may produce artifacts, but
more importantly because imaging features can be used to
choose the optimal biopsy location (e.g., enhancing area of
a large tumor) and the optimal biopsy route to prevent
spreading of tumor cells through multiple compartments
[3]. MRI is the imaging modality of choice since it has the
best tissue discrimination and allows multiplanar imaging.
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Conventional radiography can be used to detect bone
involvement and calcifications in the tumor [4]. The final
diagnosis of STS is made histologically, allowing differ-
entiation between benign and malignant masses and, in
case of malignancy, to establish the histological grade and
subtype of sarcoma. Treatment of STS requires a multi-
disciplinary approach. Surgery remains the therapeutic
modality of choice, but the extent of surgery required for
STS, as well as the role of additional radiotherapy and
chemotherapy, either pre- or postoperatively, is still the
subject of research and discussion [2].
In 2002 the World Health Organization (WHO) released
a new classification of soft tissue tumors [1] to establish a
uniform and comprehensive nomenclature for the soft
tissue tumor subtypes, with inclusion of the many
commonly used synonyms (Table 1). Tumors were divided
into nine groups: adipocytic tumors, fibroblastic/myofi-
broblastic tumors, so-called fibrohistiocytic tumors,
smooth muscle tumors, pericytic (perivascular) tumors,
skeletal muscle tumors, vascular tumors, chondro-osseous
tumors, and tumors of uncertain differentiation. Tumors in
these groups were subdivided into four categories accord-
ing to their biological behavior: benign, intermediate
(locally aggressive), intermediate (rarely metastasizing),
and malignant. In this review we discuss the imaging
characteristics of malignant soft tissue tumors with a focus
on tumors occurring in the extremities and provide an
overview of differentiating features.
Adipocytic tumors
Dedifferentiated liposarcoma
Dedifferentiated liposarcomas are malignant adipocytic
tumors showing transition from atypical lipomatous tumor/
well-differentiated liposarcoma (ALT/WDL, intermediate
(locally aggressive) tumors according to the WHO classi-
fication) to a nonlipogenic sarcoma of variable histological
grade. Dedifferentiated areas most frequently resemble
unclassified pleomorphic sarcoma, but may exhibit heter-
ologous differentiation (e.g., myogenic, osteo/chondrosar-
comatous) [1]. Dedifferentiation can occur in primary
lesions but more often in recurrences or metastases.
Dedifferentiation is seen in up to 10% of ALT/WDL,
most often in RP tumors [5]. On MRI, ALT/WDL present
as predominantly lipomatous tumors with thick septa
(>2 mm), globular and/or nodular areas, and/or associated
masses [6]. The nonlipomatous component has low signal
intensity (SI) on T1-weighted images (T1WI) and various
SIs on T2WI, depending on the type of tissue present.
The thick septa or nodules enhance markedly after con-
trast administration [7–9]. Differentiation between well-
differentiated and dedifferentiated liposarcoma by using
MR imaging is difficult. As dedifferentiation occurs within
the well-differentiated liposarcoma, imaging characteristics
are similar. Dedifferentiation is suggested by the additional
presence of a focal nodular nonlipomatous region greater
than 1 cm in size with a low to intermediate SI on T1WI
and intermediate to high SI on T2WI [9]. Clinically
dedifferentiation is suspected when a tumor suddenly
increases in size (Fig. 1).
Myxoid liposarcoma
Myxoid liposarcomas are the second most common
subtype of liposarcoma and they occur mainly in young
adults, often in the deep soft tissues of the thigh. Macro-
scopically myxoid liposarcomas are well-circumscribed,
multinodular, intramuscular tumors without prominent
tumor necrosis. They may have large mucoid pools
creating a “pulmonary edema” growth pattern. Myxoid
liposarcomas often recur and metastasize to unusual
Table 1 Synonyms used for soft tissue tumor subtypes
Myxoid liposarcoma Myxoid/round cell liposarcoma, round cell liposarcoma
Myxofibrosarcoma Myxoid MFH
Low grade fibromyxoid sarcoma Hyalinizing spindle cell tumor with giant rosettes, fibrosarcoma fibromyxoid type
UPS MFH
Embryonal RMS Myosarcoma, malignant rhabdomyoma, rhabdomyosarcoma, rhabdopoietic sarcoma,
rhabdosarcoma, embryonal sarcoma
Alveolar RMS Rhabdomyoblastoma, rhabdomyopoietic sarcoma, monomorphous round cell rhabdomyosarcoma
Epithelioid haemangioendothelioma Intravascular bronchioloalveolar tumor, angioglomoid tumor, myxoid angioblastomatosis
Angiosarcoma of soft tissue Lymphangiosarcoma, hemangiosarcoma, hemangioblastoma, malignant hemangioendothelioma,
malignant angioendothelioma
Extraskeletal osteosarcoma Soft tissue osteosarcoma
Synovial sarcoma Tendosynovial sarcoma, synovial cell sarcoma, malignant synovioma, synovioblastic sarcoma
Clear cell sarcoma Malignant melanoma of soft parts
Extraskeletal myxoid chondrosarcoma Chordoid sarcoma
locations such as the RP and the opposite extremity, even
before spreading to the lungs [1, 5]. On MRI tumors are
characterized by lacy or linear foci of high SI within a low
intensity mass on T1WI. The foci represent small quantities
of fat within the tumor, usually no more than 10% of the
total volume [10]. Tumors have a high SI on T2WI, due to
the myxoid matrix, and most show heterogeneous en-
hancement with nonenhancing areas of mucinous material
and enhancing areas with high vascularity and cellularity
[7–9, 11]. Some present as cystic masses with sharply
demarcated margins, which can lead to misdiagnosis as a
benign cyst. However, after contrast administration these
tumors show a solid area with intense enhancement [12].
The round cell (highly cellular) variant has a nonspecific
heterogeneous appearance (Fig. 1).
Pleomorphic liposarcoma
Pleomorphic liposarcomas are the least common subtype of
liposarcoma and they occur in elderly patients, mainly in
the deep soft tissues of the extremities. Macroscopically
pleomorphic liposarcomas can be well circumscribed but
nonencapsulated, as well as ill defined and infiltrative and
they contain myxoid areas, areas of necrosis and/or
hemorrhage, and a variable number of pleomorphic
lipoblasts [1, 5]. On MRI pleomorphic liposarcomas are
difficult to differentiate from other aggressive sarcomas
because they present as heterogeneous masses (low on
T1WI, high on T2WI, with heterogeneous enhancement)
and because they contain little or no fat. They usually show
well-circumscribed margins [7–9] (Fig. 1).
(Myo)fibroblastic tumors
Adult fibrosarcoma
Adult fibrosarcoma has become a rare diagnosis as most
tumors that were formerly classified as fibrosarcoma are
nowadays classified as fibromatosis, pleomorphic sarcoma,
malignant peripheral nerve sheath tumor (MPNST), and
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Fig. 1 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
adipocytic tumors. MRI of dedifferentiated liposarcoma (top row)
obtained using coronal T2WI with fat-suppression and T1WI after
contrast administration; myxoid liposarcoma (middle row) obtained
using axial T1WI before and after contrast administration; pleo-
morphic liposarcoma (bottom row) obtained using axial T1WI
before contrast administration and T1WI with fat-suppression after
contrast administration. For sites of involvement darker gray
indicates higher frequency. RP retroperitoneum
synovial sarcoma based on specific immunohistochemical
and/or molecular techniques. Adult fibrosarcoma is no
longer considered a separate entity and is therefore not
included in this discussion.
Myxofibrosarcoma
Myxofibrosarcomas are among the most common sarco-
mas in elderly patients and they mainly occur in the
superficial soft tissues of the lower limbs. Histologically
myxofibrosarcomas show multinodular growth with in-
complete fibrous septa and a myxoid stroma, with a broad
spectrum of cellularity, pleomorphism, and proliferative
activity [1, 5]. Myxofibrosarcomas resemble myxoid
liposarcomas due to their myxoid and multinodular nature.
The lesions often show intermediate SI on T1WI and high
SI on T2WI with low SI septa [10]. After contrast
administration heterogeneous nodular and peripheral con-
trast enhancement is seen [13]. Cystic formation is possible
[13, 14]. Fat is not present in myxoid MFH so this can be
used to differentiate myxofibrosarcomas from myxoid
liposarcomas. Wada et al. published a case report of a
myxofibrosarcoma with infiltrative growth pattern (no
apparent nodular lesion). The tumor spread along the
fascial planes and muscles and showed low SI on T1WI
and high SI on T2WI without calcifications on plain
radiography [15] (Fig. 2).
Low grade fibromyxoid sarcoma
Low grade fibromyxoid sarcomas occur in the proximal
extremities or trunk of young to middle-aged adults.
Typically these sarcomas are well-circumscribed masses
without hemorrhage or necrosis [5]. Histologically the
tumors consist of bland spindle-shaped cells in a variably
fibrous and myxoid stroma, alternating in different areas of
the tumor [1, 5], resulting in slightly inhomogeneous
masses with intermediate SI on T1WI and high SI on
T2WI. De Schepper et al. described a case of a well-
circumscribed low grade fibromyxoid sarcoma with pe-
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Fig. 2 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
(myo)fibroblastic tumors. MRI obtained using axial T1WI before
and after contrast administration. Low grade fibromyxoid sarcoma
(middle row) images courtesy of Dr. C.S.P. van Rijswijk, Leiden
UniversityMedical Center, Leiden, theNetherlands. For sites of involve-
ment darker gray indicates higher frequency. RP retroperitoneum
ripheral contrast enhancement and progressive central
filling [10]. Koh et al. described two cases. One was well
circumscribed with multiple intralesional nodules, some
with a target-like appearance, the other showed invasive
features without multinodularity. Both showed heteroge-
neous contrast enhancement [16] (Fig. 2).
Sclerosing epithelioid fibrosarcoma
Sclerosing epithelioid fibrosarcomas are rare sarcomas of
fibroblastic nature simulating poorly differentiated carci-
noma or sclerosing lymphoma. Median age of occurrence
is 45 years. The main sites of involvement are the lower
extremities and limb girdle. Tumors can contain myxoid,
cystic, and calcified areas but necrosis is uncommon [1, 5].
These tumors can present as a painful mass. Christensen et
al. described a case of sclerosing epithelioid fibrosarcoma
with a zonal architecture on MRI: a large central core of
very low SI and a peripheral rim of intermediate to high
SI on both T1WI and T2WI [17]. Despite their well-
circumscribed appearance on MRI, infiltrative margins
are commonly found, leading to a local recurrence rate of
more than 50% [1] (Fig. 2).
So-called fibrohystiocytic tumors
Undifferentiated pleomorphic sarcoma
Undifferentiated pleomorphic sarcomas (UPS) are tu-
mors formerly known as malignant fibrous histiocytoma
(MFH). MFH used to be regarded as a distinct tumor
type derived from histiocytes representing the most
common type of soft tissue sarcoma in adults. However,
in recent years this has been abandoned and it is now
considered to be a morphologic manifestation of a
variety of poorly differentiated neoplasms. UPS are
tumors without specific light microscopic features apart
from collagen production and UPS is therefore a
diagnosis of exclusion. Histologically they are very
heterogeneous in appearance and cellularity, but they all
contain pleomorphic cells. Some forms have abundant
giant cells or a diffuse inflammatory component (giant
cell/inflammatory UPS). Undifferentiated pleomorphic
sarcomas typically present as painless, circumscribed,
multinodular, lobulated tumors with degeneration. The
inflammatory variant may present with systemic symp-
toms, such as fever and weight loss and leukocytosis.
Calcification or ossification within the tumor can be
seen in 5–20% of cases, usually curvilinear or
punctuate, at the periphery of the lesion. Bone erosion
or infiltration is common [1, 5]. On MRI SI is
nonspecific, depending on the cellularity and myxoid
content of the lesion and the presence of hemorrhage,
necrosis, and/or calcification. Contrast enhancement is
often more pronounced in the tumor periphery than in the
tumor center because of central location of hemorrhage,
necrosis, and myxoid components [13, 14, 18]. Tateishi
et al. described 11 pleomorphic/storiform MFHs of the
chest wall. Signal characteristics on MRI were high SI on
T2WI (all), inhomogeneous enhancement in eight, and
homogeneous enhancement in three, all three of which
were localized lesions, containing fibrous component and
no degeneration [14] (Fig. 3).
Smooth muscle tumors
Leiomyosarcoma
Leiomyosarcomas are tumors composed of cells showing
distinct smooth muscle features. The most common sites of
involvement are the RP and large blood vessels, but
leiomyosarcomas also account for approximately 10% of
limb sarcomas. Leiomyosarcomas occur in intramuscular
and subcutaneous locations. Borders of the superficial
tumors are often better defined than their deep counter-
parts. Histologically they are usually highly cellular but
areas of fibrosis, myxoid change, and necrosis may be
present [1, 5]. Leiomyosarcomas usually present as non-
specific soft tissue masses with low–intermediate SI on
T1WI and high SI on T2WI [18]. Leiomyosarcomas are
mostly irregular, poorly outlined tumors without a limiting
membrane [19]. Large masses usually show central
necrosis and a thick, irregular rim-like enhancement after
contrast administration on MRI, with bone involvement in
10% of cases [10] (Fig. 4).
Skeletal muscle tumors
Embryonal rhabdomyosarcoma
Embryonal rhabdomyosarcomas (RMS) are primitive
tumors with features of embryonic skeletal muscle.
Commonly involved sites are head and neck and
the genitourinary system; less than 10% occur in the
extremities. RMS usually occur in children under the
age of 10 years. Histologically RMS consist of primitive
mesenchymal cells in various stages of myogenesis,
forming alternating regions of dense cellularity and
loose myxoid tissue. Bone destruction is found in
approximately 25% [1, 5]. In general RMS present as
heterogeneous, poorly circumscribed masses with iso-
intense to hyperintense SI compared with muscle on
T1WI and high SI on T2WI, with marked heterogene-
ous contrast enhancement. These MRI characteristics
are not specific for RMS and, except for the presence
of necrosis, do not differ among subtypes [20, 21].
In embryonal RMS hemorrhage, necrosis, and calci-
fications are rare, resulting in a more homogeneous
enhancement pattern. Hagiwara et al. described four
rhabdomyosarcomas in the head and neck region with
multiple ring enhancing areas resembling bunches of
grapes and suggested that this can be characteristic of
rhabdomyosarcoma. They called it the “botyroid sign”
[21] (Fig. 5).
Alveolar rhabdomyosarcoma
Alveolar rhabdomyosarcomas are primitive, malignant,
round cell neoplasms that show partial skeletal muscle
differentiation. Alveolar rhabdomyosarcomas commonly
arise in the extremities but have no real favored site of
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Fig. 4 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
smooth muscle tumors. MRI obtained using axial T1WI before and
after contrast administration. For sites of involvement darker gray
indicates higher frequency. RP retroperitoneum, BV blood vessels,
VCI vena cava inferior
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Fig. 3 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
so-called fibrohistiocytic tumors. MRI obtained using axial T1WI
before and after contrast administration. For sites of involvement
darker gray indicates higher frequency. UPS undifferentiated
pleomorphic sarcoma, RP retroperitoneum
origin. Median age of occurrence is 8 years but they can
occur at all ages [1, 5]. Alveolar rhabdomyosarcomas
contain fibrovascular septa that separate the tumor into
nests accounting for their alveolar appearance [22]. They
present as infiltrative, expansile, soft tissue masses,
characterized by multiple areas of necrosis [10]. High
flow vessels can be seen, as well as a lobular appearance
after contrast administration, but other signal character-
istics are nonspecific [20] (Fig. 5).
Pleomorphic rhabdomyosarcoma
Pleomorphic rhabdomyosarcomas are high grade sarcomas
consisting of bizarre cells which display evidence of
muscle differentiation. In contrast to the other subtypes
pleomorphic rhabdomyosarcomas occur almost exclu-
sively in adults, mainly in the deep soft tissues of the
extremities. Pleomorphic rhabdomyosarcomas contain
variable amounts of hemorrhage and necrosis [1, 5]. Signal
characteristics are nonspecific: isointense to skeletal mus-
cle on T1WI and heterogeneous SI on T2WI. Necrotic foci
are readily identifiable in many cases [1]. Pleomorphic
rhabdomyosarcomas have been shown to present with
areas of necrosis alternating with areas of marked
enhancement and areas of ring-like enhancement around
areas of low SI [10] (Fig. 5).
Vascular tumors
Epithelioid hemangioendothelioma
Epithelioid hemangioendotheliomas (EHE) are rare vascular
tumors, occurring at nearly all ages except in early childhood.
Most originate from a small vessel, usually a small vein. EHE
classically present as fusiform intravascular masses which
may resemble a thrombus, expanding the originating vessel
without disturbing its architecture. EHE lumens are filled
with necrotic debris and dense collagen. EHE are solitary
tumors, occurringmainly in either the superficial or deep soft
tissues of the extremities and often present as painful
nodules, sometimes associated with edema and thrombo-
flebitis [1, 5]. MRI characteristics of hemangioendothelioma
Fig. 5 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
skeletal muscle tumors. MRI of embryonal RMS (top row) obtained
using axial T1WI and T1W subtraction image after contrast
administration (dark enhancing); alveolar RMS (middle row)
obtained using sagittal T1WI before contrast administration and
T1WI with fat-suppression after contrast administration, images
courtesy of Dr. R.R. van Rijn, Academic Medical Center Amster-
dam, the Netherlands; pleomorphic RMS (bottom row) obtained
using axial T1WI before and after contrast administration. For sites
of involvement darker gray indicates higher frequency. RMS
rhabdomyosarcoma, GU genitourinary, RP retroperitoneum, Abd
abdominal
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and angiosarcoma are nonspecific [23]. Prominent serpentine
vessels may be present. SI of the vascular channels is flow-
dependent. Sometimes areas with high SI on T1WI can be
seen, corresponding to hemorrhage. The presence of necrosis
in the tumor is indicative of malignancy [10] (Fig. 6).
Angiosarcoma of soft tissue
Soft tissue angiosarcomas (AS) are malignant tumors
containing cells with morphologic and functional features
of endothelial cells. Most AS are cutaneous tumors, less
than 25% present as deep soft tissue masses. AS generally
contain both epithelioid and spindle cell areas, forming
rudimentary infiltrating vascular channels. Hemorrhage is
common and often extensive. AS present as enlarging
masses with or without systemic symptoms such as
coagulopathy, anemia, hematomas, and bruisability. Asso-
ciations are described with several conditions: (M)PNST,
NF-1, implanted foreign materials, Klippel–Trenaunay,
and previous irradiation [1, 5]. Angiosarcomas show low–
intermediate SI on T1WI and relatively high and low signal
components on T2WI with marked heterogeneous contrast
enhancement. SI on T2WI may reflect the relative propor-
tion of vascular space, cellularity, and stroma in the tumor
[24–26] (Fig. 6).
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Fig. 7 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
chondro-osseous tumors. MRI obtained using axial T1WI before
and after contrast administration. For sites of involvement darker
gray indicates higher frequency
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Fig. 6 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
vascular tumors. MRI of epithelioid hemangioendothelioma (top
row) obtained using coronal T1WI before contrast administration
and axial T2WI, images courtesy of Dr. J.C. Vilanova et al., Clinica
Girona, Girona, Spain; angiosarcoma (bottom row) obtained using
axial T1WI before contrast administration and T1W subtraction
image after contrast administration (dark enhancing). For sites of
involvement darker gray indicates higher frequency
Chondro-osseous tumors
Extraskeletal osteosarcoma
Extraskeletal osteosarcomas (EO) are malignant mesenchy-
mal tumors composed of neoplastic cells that resemble
osteoblasts and synthesize bone. All contain bone but they
may also have cartilaginous and fibroblastic components. No
other lines of differentiation are evident. The most common
site of involvement is the thigh. EO are large, deep-seated
soft tissue masses with a variable amount of mineralization.
EO do not arise from bone but may secondarily involve
periosteum, cortex, or the medullary canal. Most develop de
novo but associations have been found with previous
irradiation and trauma [1, 5]. On MRI EO often present as
well-circumscribed inhomogeneous masses on T1WI and
T2WI with inhomogeneous contrast enhancement. Calcifi-
cation is present in up to 70% of lesions (presenting as signal
voids on all sequences), usually with a large amount of
calcific and/or osteoid material. In contrast to myositis
ossificans mineralization occurs mainly in the center of the
lesion. Fluid–fluid levels are often present. Necrosis, hem-
orrhage, and cystic change are common. Tumors are often
pseudoencapsulated [10, 27, 28] (Fig. 7).
Tumors of uncertain differentiation
Synovial sarcoma
Synovial sarcomas are mesenchymal spindle cell tumors
which display variable epithelial differentiation, includ-
ing glandular formation. Histologically there are two
types: biphasic and monophasic. The biphasic variant
has epithelial and spindle cell components. The mono-
phasic variant contains only spindle cells, often with a
hemangiopericytomatous vascular pattern. SS is unre-
lated to synovium: less than 5% of SS originate in a
joint or bursa. The main sites of involvement are the
deep soft tissues of the extremities, especially around
the knee and adjacent to joints or tendon sheaths [1, 5].
Synovial sarcomas are multilobular, septated masses that
show heterogeneous SI on T1WI and T2WI and
heterogeneous contrast enhancement. Heterogeneity is
caused by areas of necrosis, calcification, cysts, and
hemorrhage within the tumor [10, 11]. Triple SI on
T2WI (SI is hypo-, iso-, and hyperintense relative to fat)
is not specific but suggestive of the diagnosis [29, 30].
Calcification is seen in a third of cases. Focal calcifi-
cation or ossification ranging from fine stippling to
marked calcifications in the periphery of the lesion can
be found [18, 31]. Fluid–fluid levels can be present.
Smaller lesions can be well-circumscribed and homo-
geneous and can be mistaken for a benign cystic mass
[32]. Up to 20% show erosion or invasion of adjacent
bone [33] (Fig. 8).
Clear cell sarcoma of soft tissue
Clear cell sarcomas of soft tissue are tumors with
melanocytic differentiation, typically involving tendons
and aponeuroses. The principal sites of involvement are the
extremities, mainly the foot and ankle. These tumors occur
mainly in young adults. Pain/tenderness is a symptom in
about 50%. Histologically clear cell sarcomas of soft tissue
present with a uniform, nested, or fascicular growth pattern
with thin fibrous septa delineating the tumor cell nests.
Melanin and/or giant cells are present in about 50% of
cases. Differentiation from malignant melanoma is im-
possible on morphological grounds [1, 5]. On MRI clear
cell sarcomas usually present as well-circumscribed lesions
with variable SI on T1WI and T2WI. About 50% of tumors
are slightly hyperintense to muscle on T1WI, probably due
to the presence of melanin, and markedly hyperintense to
muscle on T2WI [34]. Hourani et al. suggested that clear
cell sarcoma should be suspected in a lesion which displays
high SI on all sequences, including fat-sat techniques [35].
As clear cell sarcomas are often well-defined and homo-
geneous and rarely show bone destruction or necrosis, they
are often misdiagnosed as benign lesions [10, 31, 33–36]
(Fig. 8).
Epithelioid sarcoma
Epithelioid sarcomas are tumors of unknown lineage
with predominantly epithelioid cytomorphology. They
may be misdiagnosed as benign granulomatous pro-
cesses such as rheumatoid nodules. Macroscopically
these tumors are small ill-defined dermal or subcuta-
neous nodules or larger deeper masses involving
tendons or fascia. The center of these sarcomas is
usually necrotic or hemorrhagic. The main sites of
involvement are the flexor surfaces of the hand and
forearm. Epithelioid sarcomas occur mainly in young
adults. Epithelioid sarcomas are reported to be homo-
geneous or heterogeneous depending on their location
(superficial: homogeneous, deep: heterogeneous) and
they are mostly isointense to muscle on T1WI and
hyperintense on T2WI with strong enhancement [10,
33]. Chao et al. described a case of epitheloid sarcoma
of the thigh presenting as a subcutaneous multinodular
mass with a central area of hypointensity and a
peripheral portion with serpiginous hyperintensity.
Calcifications were present but not visible on MRI
[37]. Zevallow-Gieampietri et al. described two cases
of epithelioid sarcoma in the perineum. The first tumor
was a well-circumscribed mass with homogeneous
enhancement. The second tumor was a nonencapsulated
tumor, showing heterogeneous enhancement involving
subcutaneous tissue and muscle tissue. Neither tumor
showed calcifications or bone or skin involvement [38]
(Fig. 8).
Alveolar soft part sarcoma
Alveolar soft part sarcomas (ASPS) are tumors with a high
vascularity causing pulsations or bruits over the tumor. The
main sites of involvement are the extremities. ASPS mainly
occur in young adults. Histologically, tumor cells grow in an
organoid or nesting pattern [1, 5]. Nests are separated by
connective tissue containing sinusoidal vascular channels
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Fig. 8 Left to right Histological image, MR images, most common
sites of involvement, male/female ratio, and age distribution of the
tumors of uncertain differentiation. MRI obtained using axial T1WI
before and after contrast administration. For sites of involvement
darker gray indicates higher frequency
resulting in hypervascular lesions with prominent draining
veins on angiography or MRA [39]. ASPS are usually
heterogeneous, well-circumscribed lesions with high SI on
T1WI and T2WI and intense inhomogeneous contrast
enhancement [10]. High SI on T1WI with numerous signal
voids is very suggestive of ASPS, the signal voids
suggesting rapid flow within distended vessels; however,
not all tumors show these signal characteristics. Arteriove-
nousmalformations (AVM) show similar characteristics, but
in ASPS an accompanying soft tissue mass is present [40].
Bone erosion may be found but is uncommon [33] (Fig. 8).
Extraskeletal myxoid chondrosarcoma
Extraskeletal myxoid chondrosarcomas (EMC) are multinod-
ular tumors with abundant myxoid matrix and malignant
chondroblast-like cells arranged in networks. Despite the
name there is no convincing evidence of cartilaginous
differentiation. Main sites of involvement are the deep soft
tissues of the proximal extremities. Tumors usually do not
contain calcification or bone formation and do not involve
adjacent bone. EMCappear as a lobulated soft tissuemass and
are usually inhomogeneous and ill-defined, but well deli-
neated and homogeneous variants have been described. On
T1WI SI is variable, from equal to muscle to equal to fat. On
T2WI SI is as high as or higher than fat. Highly myxoid
tumors may have a homogeneous very high SI on T2WI,
resembling a cyst or myxoma. Tumors with necrosis or
hemorrhage show amore heterogeneous signal [1, 10] (Fig. 8).
Differentiating features
Differentiating between the subtypes of sarcoma is
difficult, partly because soft tissue sarcomas are rare
tumors, making it difficult to obtain a large series of each
subtype, but also because the subtypes are very similar in
appearance. The sarcomas are mostly large, deep-seated
tumors, often with hemorrhage and necrosis, making them
inherently inhomogeneous masses. There are, however,
factors which can help to narrow down the number of
possibilities. Important differentiating factors are age and
location, the presence or absence of pain, as well as (MR)
imaging characteristics (Table 2).
Age
Embryonal and alveolar rhabdomyosarcomas mainly occur
in children; sarcomas of uncertain differentiation in young
adults; and UPS, liposarcoma, leiomyosarcoma, and pleo-
morphic rhabdomyosarcomas in older adults (Fig. 9).
Location
Tumor location (deep/superficial, site of involvement) is
also an important differentiating factor. Most tumors are
deep seated, but some subtypes, such as myxofibrosarco-
mas, epithelioid sarcomas, and angiosarcomas, are com-
monly superficially located. Although most soft tissue
sarcomas occur in the proximal lower extremity, some are
more common in other locations. Clear cell sarcoma, for
example, most commonly occurs in the foot, epithelioid
sarcoma in the flexor surface of the arm, and synovial
sarcoma near (but not in) joints. Clear cell sarcoma,
synovial sarcoma, and epithelioid sarcoma are often
associated with tendons/aponeuroses.
Table 2 Differentiating features between sarcoma subtypes
Calcification Well-differentiated liposarcoma, undifferentiated pleomorphic sarcoma, extraskeletal osteosarcoma,
synovial sarcoma
No/little necrosis Myxoid liposarcoma, low grade fibromyxoid sarcoma, sclerosing epithelioid fibrosarcoma, embryonal
rhabdomyosarcoma, clear cell sarcoma
Pain Sclerosing epithelioid fibrosarcoma, pleomorphic rhabdomyosarcoma, epithelioid hemangioendothelioma,
large angiosarcoma, extraskeletal osteosarcomas, synovial sarcoma, clear cell sarcoma
Superficial Myxofibrosarcoma, angiosarcoma, epithelioid sarcoma, leiomyosarcoma, epithelioid hemangioendothelioma
Ill-defined Alveolar rhabdomyosarcoma, pleomorphic rhabdomyosarcoma, epithelioid sarcoma, alveolar soft part sarcoma
Bone destruction Undifferentiated pleomorphic sarcoma, leiomyosarcoma, rhabdomyosarcoma, synovial sarcoma
Associated with tendons Clear cell sarcoma, synovial sarcoma, epithelioid sarcoma
Lymph node metastases Epithelioid sarcoma, synovial sarcoma, rhabdomyosarcoma, clear cell sarcoma, angiosarcoma
10 20 30 40 50 60 70
RHABDO 
(EMBR / ALV)
SYNOVIAL
EPITHELIOID
ALV SOFT PART
CLEAR CELL  
LIPO (MYXOID) 
L GR FIBROMYX
0
Age
UPS
RHABDO (PLEO)
LIPO (DEDIF / PLEO)
Fig. 9 Age distribution of some of the subtypes of soft tissue
sarcoma
Pain
Whereas most sarcomas are painless masses, pain is
commonly found in sclerosing epithelioid fibrosarcoma,
pleomorphic rhabdomyosarcoma, epithelioid hemangioen-
dothelioma, large angiosarcoma, extraskeletal osteosarco-
ma, synovial sarcoma, and clear cell sarcoma.
Lymph node metastases
Most soft tissue sarcomas metastasize hematogenously,
mainly to the lung. A few subtypes of sarcoma are known
to show lymph node metastases: epithelioid sarcoma,
synovial sarcoma, rhabdomyosarcoma, clear cell sarcoma,
and angiosarcoma [2].
MR imaging features
Although the role of MRI in evaluating the extent of
sarcomas has already been established, its ability in
differentiating between benign and malignant lesions and
between the various subtypes of sarcoma is still con-
troversial as most soft tissue tumors have nonspecific
imaging findings: intermediate SI on T1WI, high SI on
T2WI, and heterogeneous enhancement after contrast
administration, due to the presence of hemorrhage and
necrosis in the tumor [41]. MR imaging features can,
however, be of help in the differential diagnosis if lesions
have an atypical appearance, e.g., high SI on T1WI and/or
low SI on T2WI. Fat, blood products, and proteinacious
fluids have a high SI on T1WI. Therefore dedifferentiated
liposarcomas are mostly bright on T1, and myxoid
liposarcoma may show areas of high SI within a low SI
mass. High SI on T1WI is also a characteristic feature of
alveolar soft part sarcoma. Fibrous tissue, deoxyhemoglo-
bin, hemosiderin, calcium, and air have a low SI on T2WI.
Tumors containing fibrous tissue, such as low grade
fibrosarcomas and UPS therefore present with areas of low
SI on T2WI. Clear cell sarcomas may show both
hyperintense areas on T1WI and hypointense areas on
T2WI because of the presence of melanin in the tumor
(melanin causes shortening of T1 and T2 relaxation times).
Calcifications are also a differentiating feature: they can be
seen in among others well-differentiated liposarcoma,
undifferentiated pleomorphic sarcoma, extraskeletal osteo-
sarcoma, and synovial sarcoma. Necrosis is common in
most soft tissue sarcomas except in myxoid liposarcomas,
low grade fibromyxoid sarcoma, sclerosing epithelioid
fibrosarcoma, embryonal rhabdomyosarcoma, and clear
cell sarcoma.
In conclusion, althoughMR characteristics alone are often
insufficient to differentiate between the subgroups of soft
tissue sarcomas, MRI can limit the number of possibilities
and provide important information regarding the optimal
biopsy site and tumor extent. Combination of clinical,
histological, and imaging characteristics remains essential in
the diagnosis and treatment of soft tissue sarcomas.
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